IRIS: Who We Help

The IRIS team is working with health care providers and payers across the country to simply and affordably provide Diabetic Retinopathy assessments to their diabetic patient populations — conveniently in the primary care setting.

Founded by physicians, we place the highest priority on anticipating the needs of each player in the broader healthcare landscape, with an overall objective to end preventable blindness, enhance early detection of other diseases, lower systemic costs, increase quality outcomes and impact patient satisfaction.

Call 1-888-535-2574 for expert advice on improving your eye exam scores to over 80% compliance.

Patients

Patients

An IRIS retinal screening is a quick, painless way to detect problems even before they affect your vision—right in your doctor’s office.

  • Retinopathy is the leading cause of preventable blindness in the United States in people 20 to 65 years of age
  • Ask your doctor about the quick and painless scan
  • You’ll have peace of mind with one simple test
Learn More
Physicians

Physicians

IRIS is a great way to better serve your population of diabetic patients with a quick, convenient retinal scan right in your practice.

  • Any staff member can administer the simple automated screening
  • Other physicians across the country report minimal impact on patient flow and often report new efficiencies due to IRIS
  • You receive a clear and simple report of findings from a highly trained retina specialist
Learn More
Health Systems

Health Systems

IRIS technology can scale with the demands of any size health system. Some IRIS clients serve tens of thousands of diabetic patients and some serve smaller numbers.

  • Our change management experts are a resource to ensure the ongoing success of IRIS in your health system
  • IRIS has increased the percentage of screened patients to over 70% for some providers
  • Early adopters have seen measurable improvement in HEDIS quality measures
Learn More
Insurers and Payors

Insurers and Payors

A simple and low-cost IRIS screening can provide a window into each patient’s overall health. The indication of diabetic retinopathy is a biomarker that can classify patients as having a higher risk for other disease processes — ultimately enhancing preventative care throughout the healthcare system.

  • IRIS helped an insurance payor achieve a five star HEDIS rating
  • Our change management experts support provider teams every step of the way
Learn More
Employers

Employers

Diabetic retinopathy is the leading cause of preventable blindness in working-age adults in the United States.

  • The American Academy of Ophthalmology recommends that anyone with diabetes receive a retinal eye exam every year
  • IRIS screenings provide higher quality preventative care while lowering health care costs and dramatically expanding patient accessibility
Learn More
Diabetic Educators

Diabetic Educators

An IRIS preventative screening is as simple and quick as taking your blood pressure or stepping on a scale — and can be just as helpful to diabetic educators and quality care teams in helping determine the risk level of their patients.

  • Providers can increase their screening rates of diabetic populations beyond 80%
  • IRIS is proven to help providers serve diabetic populations more efficiently
  • The IRIS team is committed to quality outcomes while reducing systemic costs
Learn More